Meta-analysis of a controlled study of levosimendan combined with Sacubitril/Valsartan for the treatment of heart failure with reduced ejection fraction in China
ObjectiveLevosimendan and Sacubitril/Valsartan are both potent pharmacotherapeutic agents in the clinical management of heart failure characterized by reduced ejection fraction. However, the limited efficacy of monotherapy and the lack of extensive clinical experience with combination therapy necess...
Gardado en:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2024-10-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Assuntos: | |
| Acceso en liña: | https://www.frontiersin.org/articles/10.3389/fcvm.2024.1469457/full |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|